Expertise in
7
conditions

Anthony J. Chalmers

Glasgow, SCT, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
7
conditions
Glasgow, SCT, GB 

Overview

Anthony Chalmers practices practicing medicine in Glasgow, United Kingdom.

Mr. Chalmers is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.

He is actively involved in clinical research, co-authoring 124 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Glasgow, SCT, United Kingdom
Other Locations
Leeds, ENG, United Kingdom
Garscube Estate, Switchback Road, Bearsden, SCT G611QH, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A British Feasibility Study of Molecular Stratification and Targeted Therapy to Optimize the Clinical Management of Patients With Glioma by Enhancing Clinical Outcomes, Reducing Avoidable Toxicity, Improving Management of Post-operative Residual & Recurrent Disease and Improving Survivorship
A British Feasibility Study of Molecular Stratification and Targeted Therapy to Optimize the Clinical Management of Patients With Glioma by Enhancing Clinical Outcomes, Reducing Avoidable Toxicity, Improving Management of Post-operative Residual & Recurrent Disease and Improving Survivorship
Enrollment Status: Recruiting
Publish Date: May 05, 2026
Intervention Type: Other
A Cancer Research UK Phase I Trial of Olaparib (AZD2281), an Oral PARP Inhibitor, in Combination With Extended Low-Dose Oral Temozolomide in Patients With Relapsed Glioblastoma
A Cancer Research UK Phase I Trial of Olaparib (AZD2281), an Oral PARP Inhibitor, in Combination With Extended Low-Dose Oral Temozolomide in Patients With Relapsed Glioblastoma
Enrollment Status: Completed
Publish Date: February 05, 2018
Intervention Type: Drug, Procedure, Genetic, Other
Study Phase: Phase 1
View 1 Less Clinical Trial

124 Total Publications

ESTRO, ESNR and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumours.
ESTRO, ESNR and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumours.
Journal: Neuro-oncology
Published: April 13, 2026

Frequently Asked Questions about Anthony J. Chalmers

Is Anthony J. Chalmers a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Anthony J. Chalmers is classified as an Elite expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anthony J. Chalmers participate in research or clinical trials?

Yes. Anthony J. Chalmers has published 124 articles and abstracts on conditions like Glioblastoma. You can view a list of Anthony J. Chalmers's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Chalmers's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile